Shushan Hovsepyan: Five open grant opportunities for pediatric oncologists
Shushan Hovsepyan shared a post on LinkedIn:
”Five open grant opportunities for pediatric oncologists!
Check out and apply to make a significant impact in the field of childhood cancer care.
Rally Foundation for Childhood Cancer Research
- Grant: A Collaborative Pediatric Cancer Research Awards Program
- Key Dates: LOI opens on August 12, 2024
- Funding Amount: 50-100.000 USD
- Apply: ProposalCentral
The Andrew McDonough B+ Foundation
- Grant: Childhood Cancer Research Grant
- Key Dates: September 3, 2024
- Funding Amount: 150.000 USD
- Apply: ProposalCentral
Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital
- Grant: Pediatric Cancer Research Fellowship
- Key Dates: August 15, 2024
- Funding Amount: 70-76.000USD
- Apply: Damon Runyon Cancer Research Foundation’s application portal
- Grant: Translation to Cure (T2C) Award and Early Investigator (EI) Award
- Key Dates: Rolling basis
- Funding Amount: 100.000 USD
- Apply: CURE Childhood Cancer website
- Grant: Curinf Kids Cancer Grant
- Key Dates: Rolling basis
- Funding Amount: 150- 300.000 USD
- Apply: ProposalCentral
Let’s create a comprehensive database of funding opportunities specifically for pediatric oncologists. If you know other grants, please add them below.”
Source: Shushan Hovsepyan/LinkedIn
Shushan Hovsepyan is a pediatric oncologist and adjunct assistant professor at the Yerevan State Medical University. Currently, she is the Editor-in-Chief of OncoDaily Medical Journal.
She completed her clinical fellowship at the National Institute of Cancer in Milan, Italy and at the St. Anna Children’s Research Hospital in Austria Furthermore, she held a research fellowship position at the European Organisation for Research and Treatment of Cancer in Brussels, Belgium.
Dr. Hovsepyan also completed the Postgraduate Harvard Medical School’s Effective Writing for Healthcare program. She is a former co-chair of the SIOP Global Health Network Education and Training Working Group.